Abstract

CTLA‐4 is an essential regulator of T‐cell immune responses whose intracellular trafficking is a hallmark of its expression. Defects in CTLA‐4 trafficking due to LRBA deficiency cause profound autoimmunity in humans. CTLA‐4 rapidly internalizes via a clathrin‐dependent pathway followed by poorly characterized recycling and degradation fates. Here, we explore the impact of manipulating Rab GTPases and LRBA on CTLA‐4 expression to determine how these proteins affect CTLA‐4 trafficking. We observe that CTLA‐4 is distributed across several compartments marked by Rab5, Rab7 and Rab11 in both HeLa and Jurkat cells. Dominant negative (DN) inhibition of Rab5 resulted in increased surface CTLA‐4 expression and reduced internalization and degradation. We also observed that constitutively active (CA) Rab11 increased, whereas DN Rab11 decreased CTLA‐4 surface expression via an impact on CTLA‐4 recycling, indicating CTLA‐4 shares similarities with other recycling receptors such as EGFR. Additionally, we studied the impact of manipulating both LRBA and Rab11 on CTLA‐4 trafficking. In Jurkat cells, LRBA deficiency was associated with markedly impaired CTLA‐4 recycling and increased degradation that could not be corrected by expressing CA Rab11. Moreover LRBA deficiency reduced CTLA‐4 colocalization with Rab11, suggesting that LRBA is upstream of Rab11. These results show that LRBA is required for effective CTLA‐4 recycling by delivering CTLA‐4 to Rab11 recycling compartments, and in its absence, CTLA‐4 fails to recycle and undergoes degradation.

Highlights

  • CTLA-4 is an essential regulatory protein involved in control of T cell immune responses and prevention of autoimmunity

  • We pursued analysis in both cell types to provide a comparison of CTLA-4 behaviour and its colocalisation with markers of intracellular compartments defined by Rab GTPase expression (Fig. 1C)

  • CTLA-4 forms a vital checkpoint in the regulation of T cell activation [30,31], inhibiting CD28 costimulation by capturing and internalising its shared ligands via transendocytosis [15]

Read more

Summary

Introduction

CTLA-4 is an essential regulatory protein involved in control of T cell immune responses and prevention of autoimmunity. CTLA-4 is expressed on T lymphocytes, and in particular on a subset of cells termed regulatory T cells (Treg) [1]. The loss of Treg [2] or the loss of CTLA-4 from Treg in mice [3] triggers fatal autoimmunity. Heterozygous missense mutations in CTLA-4 or mutations in the trafficking protein LPS-responsive beige-like anchor protein (LRBA) (which affects CTLA-4 expression) both cause clinically significant autoimmunity [4,5,6]. In addition CTLA-4 is a key target for cancer immunotherapy, whereby antibodies to CTLA-4 revolutionised cancer treatment by triggering (auto)-immune responses to tumours [7]. Understanding the cell biology of CTLA-4 is of considerable medical significance

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call